| Literature DB >> 21071432 |
Lee B Smith1, Patrick W F Hadoke, Emma Dyer, Martin A Denvir, David Brownstein, Eileen Miller, Nancy Nelson, Sara Wells, Michael Cheeseman, Andy Greenfield.
Abstract
AIMS: The vascular type of Ehlers-Danlos syndrome (EDS IV) is an autosomal-dominant disorder characterized by thin translucent skin and extensive bruising. Patients with EDS IV have reduced life expectancy (median 45-50 years) due to spontaneous rupture of arteries (particularly large arteries) or bowel. EDS IV results from mutation of the COL3A1 gene, which encodes the pro-α(1) chains of type III collagen that is secreted into the extracellular matrix, e.g. by smooth muscle cells. A mouse model of EDS IV produced by targeted ablation of Col3a1 has been of limited use as only 10% of homozygous animals survive to adulthood, whereas heterozygous animals do not die from arterial rupture. We report a novel, exploitable model of EDS IV in a spontaneously generated mouse line. METHODS ANDEntities:
Mesh:
Substances:
Year: 2010 PMID: 21071432 PMCID: PMC3058731 DOI: 10.1093/cvr/cvq356
Source DB: PubMed Journal: Cardiovasc Res ISSN: 0008-6363 Impact factor: 10.787
Penetrance of the aortic dissection phenotype in +/Col3a1▵ mice
| Mice in colony | Penetrance | ||
|---|---|---|---|
| 473 | 225 | 63 | 28% |
Echocardiographic comparison of mice carrying the mutant allele (+/Col3a1▵) with wild-type (+/+) controls
| Age | 4 weeks | 12 weeks | ||||
|---|---|---|---|---|---|---|
| Parameter | +/+ | +/ | +/+ | +/ | ||
| LV mass (mg) | 62.2 ± 6.1 | 57.5 ± 6.7 | 0.60 | 90 ± 4 | 100 ± 95 | 0.32 |
| E-wave (mm/s) | 714 ± 72 | 825 ± 68 | 0.28 | 655 ± 91 | 806 ± 178 | 0.38 |
| A-wave (mm/s) | 450 ± 78 | 492 ± 71 | 0.69 | 308 ± 35 | 491 ± 102 | 0.07 |
| Annulus (mm) | 1.13 ± 0.038 | 1.12 ± 0.06 | 0.86 | 1.42 ± 0.04 | 1.37 ± 0.04 | 0.40 |
| SV (mm) | 1.22 ± 0.05 | 1.26 ± 0.06 | 0.59 | 1.56 ± 0.05 | 1.48 ± 0.03 | 0.24 |
| STJ (mm) | 1.24 ± 0.05 | 1.23 ± 0.06 | 0.91 | 1.59 ± 0.03 | 1.49 ± 0.05 | 0.11 |
| Doppler (AA Dec) | 847 ± 100 | 912 ± 81 | 0.61 | 1270 ± 326 | 927 ± 106 | 0.37 |
| Doppler (AA Asc) | 838 ± 70 | 833 ± 111 | 0.97 | 1005 ± 102 | 970 ± 18 | 0.77 |
| DA (mm) | 1.07 ± 0.06 | 1.06 ± 0.06 | 0.92 | 1.35 ± 0.07 | 1.33 ± 0.13 | 0.88 |
| Arch (mm) | 1.09 ± 0.06 | 1.19 ± 0.06 | 0.22 | 1.43 ± 0.05 | 1.36 ± 0.03 | 0.31 |
| AscAo (mm) | 1.23 ± 0.06 | 1.22 ± 0.08 | 0.95 | 1.55 ± 0.07 | 1.50 ± 0.08 | 0.65 |
No significant differences were detected in any of the parameters measured in mice at the age of 4 weeks or, subsequently, at 12 weeks (n = 8 +/+, n = 8 +/Col3α1▵). SV, sinal valve; STJ, sinotubular junction; DA, decending aorta; AscAo, ascending aorta. Data are mean ± SEM, where n = 8 (four males, four females) per group.
Functional consequences of the Col3a1▵ mutation: agonist-selective enhancement of aortic contraction
| Drug | Endothelium | Sensitivity (−log EC50), | |||||
|---|---|---|---|---|---|---|---|
| +/+ | +/ | +/+ | +/ | ||||
| 5-HT | Intact | 7.5 ± 0.4 | 11.6 ± 1.3* | 6.70 ± 0.87 | 7.09 ± 0.22 | 0.16 | |
| Denuded | 10.5 ± 1.4 | 11.0 ± 1.9 | 0.80 | 6.85 ± 1.08 | 7.33 ± 0.14* | ||
| PhE | Intact | 5.0 ± 1.2 | 6.6 ± 1.1 | 0.24 | 7.28 ± 0.80 | 7.36 ± 0.17 | 0.77 |
| Denuded | 7.7 ± 1.8 | 6.1 ± 1.4 | 0.58 | 7.24 ± 0.96 | 7.84 ± 0.73 | 0.38 | |
Data are mean ± SEM for n mice. Comparisons were made using Student's unpaired t-test. Emax, maximum contraction; 5-HT, 5-hydroxytryptamine; PhE, phenylephrine.
*P < 0.05 compared with +/+ littermates (highlighted in bold).
Functional consequences of the Col3a1▵ mutation: aortic relaxation is unaffected in Col3a1▵ mice
| Drug | Endothelium | Sensitivity (−log IC50), | |||||
|---|---|---|---|---|---|---|---|
| +/+ | +/ | +/+ | +/ | ||||
| ACh | Intact | 81.0 ± 3.6 | 77.8 ± 7.7 | 0.72 | 7.27 ± 1.90 | 7.30 ± 0.41 | 0.92 |
| Denuded | 7.0 ± 2.3 | 3.5 ± 1.0 | 0.21 | — | — | — | |
| SN | Intact | 96.4 ± 1.8 | 99.6 ± 2.8 | 0.37 | 7.99 ± 0.15 | 8.41 ± 0.44 | 0.41 |
| Denuded | 95.5 ± 1.8 | 95.8 ± 2.1 | 0.91 | 7.65 ± 0.33 | 7.99 ± 0.47 | 0.56 | |
Data are mean ± SEM for n mice. Comparisons were made using Student's unpaired t-test. Emax, maximum relaxation; ACh, acetylcholine; SN, sodium nitroprusside. Responses to vasorelaxants were obtained after contraction with a submaximal concentration of 5-hydroxytryptamine.